Litcius/Paper detail

Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae

Anaïs Eskenazi, Cédric Lood, Julia M. Wubbolts, Maya Hites, Nana Balarjishvili, Lika Leshkasheli, Lia Askilashvili, Leila Kvachadze, Vera van Noort, Jeroen Wagemans, Marc Jayankura, Ніна Чанішвілі, Mark de Boer, Peter H. Nibbering, Mzia Kutateladze, Rob Lavigne, Maya Merabishvili, Jean‐Paul Pirnay

2022Nature Communications288 citationsDOIOpen Access PDF

Abstract

A 30-year-old bombing victim with a fracture-related pandrug-resistant Klebsiella pneumoniae infection after long-term (>700 days) antibiotic therapy is treated with a pre-adapted bacteriophage along with meropenem and colistin, followed by ceftazidime/avibactam. This salvage therapy results in objective clinical, microbiological and radiological improvement of the patient's wounds and overall condition. In support, the bacteriophage and antibiotic combination is highly effective against the patient's K. pneumoniae strain in vitro, in 7-day mature biofilms and in suspensions.

Topics & Concepts

Klebsiella pneumoniaeAntibioticsMicrobiologyColistinBacteriophageMedicineCeftazidime/avibactamMeropenemCephalosporinAntibiotic resistanceBiologyEscherichia coliGeneBiochemistryBacteriophages and microbial interactionsAntibiotic Resistance in BacteriaBacillus and Francisella bacterial research
Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae | Litcius